High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. [electronic resource]
Producer: 20050721Description: 2344-8 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Brain Neoplasms -- secondary
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cohort Studies
- ErbB Receptors -- antagonists & inhibitors
- Female
- Gefitinib
- Humans
- Incidence
- Lung Neoplasms -- drug therapy
- Male
- Meningeal Neoplasms -- secondary
- Middle Aged
- Neoplasm Staging
- Quinazolines -- therapeutic use
- Survival Rate
- Treatment Failure
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.